A102 THIOPURINE METABOLITE LEVEL MONITORING LEADS TO INDIVIDUALIZED AND OPTIMIZED THIOPURINE THERAPY IN ADULT INFLAMMATORY BOWEL DISEASE (IBD)

Documenti analoghi

• A130 TABLEAU DASHBOARD AS A QUALITY IMPROVEMENT AND STRATEGIC DRIVING TOOL IN THE IBD OUTPATIENT SETTING: EARLY EXPERIENCE FROM THE IBD CENTRE OF EXCELLENCE AT THE UNIVERSITY OF ALBERTA HOSPITAL
  di: Lytvyak, E, et al.
  Pubblicazione: (2018)
• A132 THREE QUARTERS OF INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE INFLIXIMAB THERAPY IN CLINICAL REMISSION SHOW EVIDENCE OF MUCOSAL INFLAMMATION WITH ELEVATED FECAL CALPROTECTIN
  di: Stern, N, et al.
  Pubblicazione: (2018)
• A131 ELECTRONIC HEALTH RECORD–BASED SMARTSETS INTEGRATE VARIOUS ASPECTS OF FLARE MANAGEMENT IN OUTPATIENTS WITH INFLAMMATORY BOWEL DISEASE THEREFORE ENSURING CONTINUITY OF CARE
  di: Lytvyak, E, et al.
  Pubblicazione: (2018)
• A222 EPIDEMIOLOGICAL, PHENOTYPIC AND CLINICAL PATTERNS OF EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
  di: Lytvyak, E, et al.
  Pubblicazione: (2020)
• A137 THERAPEUTIC DRUG MONITORING WITH INFLIXIMAB TROUGH LEVELS LEAD TO INCREASED INTERVENTION
  di: Stern, N C, et al.
  Pubblicazione: (2018)